Cancer Research UK, London Research Institute

"I am responsible for a 15 member lab at Clare Hall, which is funded by CRUK. Our research focuses on understanding gene expression and the maintenance of genome integrity, as well as the connection between these processes, using a combination of biochemical, genetic and cell biological techniques in both human and yeast cells.

We have been working with CRT since 2006 and they have commercialised three reagents for us – two antibodies and one plasmid, MultiDsk. Before our MultiDsk plasmid was commercialised, few choices were available to scientists.

CRT has not only commercialised these reagents so that the whole world has access to them, it has also provided my lab with good commercial returns and has removed the burden on MTA, making academic transfers a smooth and easy process."

Jesper Svejstrup,
Head of Mechanisms of Gene Transcription Laboratory, Cancer Research UK, London Research Institute, Clare Hall Laboratories